Literature data suggest that various natural and synthetic compounds, such as phytoestrogens and xenoestrogens structurally related to estrogen, may play a protective role against CRC by binding to ERβ and enhancing its anticancer function [10]. The gene discussed is ESR2; the disease is colorectal carcinoma.